LOLATAO-An Artificial-Intelligence-Based Virtual Assistant for Clinical Follow-Up of Patients with Non-Valvular Atrial Fibrillation (AF) Undergoing Oral Anticoagulant Therapy (OAT): A Feasibility Study
View abstract on PubMed
Summary
This summary is machine-generated.A speech-AI assistant, LOLATAO, successfully monitored patients with non-valvular atrial fibrillation undergoing oral anticoagulation therapy (OAT). The tool demonstrated high patient acceptance and satisfaction, aiding in medication management and reducing clinician workload.
Area Of Science
- Medical Informatics
- Artificial Intelligence in Healthcare
- Cardiology
Background
- Non-valvular atrial fibrillation (AF) management requires diligent oral anticoagulation therapy (OAT).
- Current OAT monitoring can be resource-intensive for healthcare providers.
Purpose Of The Study
- To assess the feasibility of using LOLA, a speech-AI assistant, for monitoring and managing OAT in non-valvular AF patients.
- To evaluate patient acceptance, adherence, and satisfaction with the AI-driven monitoring system.
Main Methods
- A pilot prospective observational study involving 50 non-valvular AF patients on OAT.
- Patients received initial and monthly calls from the LOLATAO speech-AI assistant.
- Satisfaction questionnaires were administered post-study.
Main Results
- LOLATAO showed high acceptability (85%), adherence (90%), and patient satisfaction (>95%).
- 18% of patients required bridging therapy, and 42% missed at least one dose.
- Significant issues with time in therapeutic range (TTR) were noted in Vitamin K antagonist users, leading to DOAC switching.
Conclusions
- LOLATAO is a feasible and effective tool for the chronic follow-up of OAT in AF patients.
- The AI assistant reduces the care burden on hematologists while maintaining high patient satisfaction.
- The system aids in identifying and managing OAT-related challenges, potentially improving patient outcomes.
Related Concept Videos
Pulse rhythm refers to the pattern of pulsations within specific intervals, offering valuable insights into the regularity or irregularity of the heart's beats as observed through the pattern of pulsation within specific intervals. A regular pulse exhibits a consistent heart rate with uniform waveforms and pulsation force, variations of which can be classified as normal, weak, or bounding.
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...

